Levetiracetam Neuraxpharm (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a crucial role in neurotransmitter release. By modulating SV2A activity, the drug stabilizes neuronal firing and decreases excessive neuronal excitability, thereby providing its anticonvulsant effect.

The dosage of Levetiracetam Neuraxpharm is individualized. A qualified prescriber determines the appropriate starting dose and titration schedule based on the patient’s age, renal function, seizure type, and clinical response. Patients should follow the prescribing clinician’s instructions precisely.

Safety data for levetiracetam in pregnancy and lactation are limited. It is classified as pregnancy category unknown, and use is recommended only when the potential benefit to the mother outweighs any possible risk to the fetus. Breastfeeding mothers should consult their healthcare provider before continuing therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproate. It generally has fewer drug‑enzyme interactions, a favorable tolerability profile, and does not require routine blood‑level monitoring, making it a convenient option for many patients.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Levetiracetam Neuraxpharm is taken orally. Swallow the tablet whole with a glass of water; it may be taken with or without food. Doses are usually divided throughout the day as directed by the prescriber to maintain stable blood levels.

Serious adverse events include severe skin reactions such as Stevens‑Johnson syndrome, suicidal ideation or behavior, marked depression, and rare blood disorders like neutropenia or thrombocytopenia. Patients should seek immediate medical attention if they notice rash, mood changes, or unexplained bruising.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, as dose adjustment may be required, and for those with a history of serious psychiatric disorders.